Grace Therapeutics Inc
Grace Therapeutics Inc (GRCE) Option Chain
As of September 24, 2026, Grace Therapeutics Inc is trading at $2.13, a -1.62% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 555.1%. IV Rank is —%.
Read more
Tracking the GRCE option chain helps you see every strike and expiry on Grace Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Grace Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GRCE options activity at a glance. Use our scanner to monitor the GRCE option chain in real time and filter for the GRCE options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GRCE stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the GRCE option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where GRCE stock options are being actively traded and where they are not.
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Grace Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen GRCE options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of GRCE stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)45
- 52 weeks high-58.30%
- 52 weeks low20.67%
- Analyst recommendationStrong Buy
1.00 - Target price$6.00
182.35% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-1.18
- EPS growth next 5 years—
As of September 24, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 78.28 | 2 | 0 | 0.40 | 0.00 | 0.05 | 0.75 | 2.50 | +15.74 | — | 2.95 | 0.37 | 2.58 | 0 | 2 | 21.72 |
| 90.23 | 0 | 0 | 3.80 | 0.00 | — | 3.80 | 5.00 | +131.48 | 0.50 | 5.30 | 2.87 | 0.03 | 0 | 0 | 9.77 |
| 94.47 | 0 | 0 | 3.80 | 0.00 | — | 3.80 | 7.50 | +247.22 | 3.00 | 7.80 | 5.37 | 0.03 | 0 | 0 | 5.53 |
As of September 24, 2026
Scan the full option chain in one place
Browse the full GRCE option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→